Autoimmunity in 2015

Carlo Selmi

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Compared to the clear trend observed in previous years, the number of peer-reviewed articles published during 2015 and retrieved using the “autoimmunity” key word declined by 4 %, while remaining 5 % of immunology articles. On the other hand, a more detailed analysis of the published articles in leading immunology and autoimmunity journals revealed exciting scenarios, with fascinating lines of evidence being supported by convincing data and likely followed by rapid translational or clinical developments. As examples, the study of the microbiome, the development of new serum or other tissue biomarkers, and a more solid understanding of disease pathogenesis and tolerance breakdown mechanisms have been central issues in the past year. Furthermore and similar to the oncology field, progress in the understanding of single autoimmune condition is becoming most specific with psoriatic and rheumatoid arthritis being ideal paradigms with treatment options diverging after decades of common therapies, as illustrated by IL17-targeting approaches. The ultimate result of these advances is towards personalized medicine with an ideal approach being tailored on a single patient, based on a finely tuned definition of the immunogenetics, epigenetics, microbiome, and biomarkers. Finally, experimental reports suggest that cancer-associated immune mechanisms or the role of T and B cell subpopulations should be better understood in autoimmune diseases. While we hailed the 2014 literature in the autoimmunity world as part of an annus mirabilis, we should not be mistaken in the strong stimulus of research in autoimmunity represented by the 2015 articles that will be summarized in this article.

Original languageEnglish (US)
Pages (from-to)110-119
Number of pages10
JournalClinical Reviews in Allergy and Immunology
Volume51
Issue number1
DOIs
StatePublished - Aug 1 2016
Externally publishedYes

Fingerprint

Autoimmunity
Microbiota
Allergy and Immunology
Biomarkers
Mirabilis
Immunogenetics
Precision Medicine
Psoriatic Arthritis
Epigenomics
Autoimmune Diseases
Rheumatoid Arthritis
B-Lymphocytes
T-Lymphocytes
Therapeutics
Serum
Research
Neoplasms

Keywords

  • Epigenetics
  • Genetics
  • Immunogenetics
  • Microbiome
  • Multiple sclerosis
  • Psoriasis
  • Psoriatic arthritis
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Th17
  • Tolerance breakdown

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Autoimmunity in 2015. / Selmi, Carlo.

In: Clinical Reviews in Allergy and Immunology, Vol. 51, No. 1, 01.08.2016, p. 110-119.

Research output: Contribution to journalReview article

Selmi, Carlo. / Autoimmunity in 2015. In: Clinical Reviews in Allergy and Immunology. 2016 ; Vol. 51, No. 1. pp. 110-119.
@article{98da96f0828346c1822dd3f2aa312201,
title = "Autoimmunity in 2015",
abstract = "Compared to the clear trend observed in previous years, the number of peer-reviewed articles published during 2015 and retrieved using the “autoimmunity” key word declined by 4 {\%}, while remaining 5 {\%} of immunology articles. On the other hand, a more detailed analysis of the published articles in leading immunology and autoimmunity journals revealed exciting scenarios, with fascinating lines of evidence being supported by convincing data and likely followed by rapid translational or clinical developments. As examples, the study of the microbiome, the development of new serum or other tissue biomarkers, and a more solid understanding of disease pathogenesis and tolerance breakdown mechanisms have been central issues in the past year. Furthermore and similar to the oncology field, progress in the understanding of single autoimmune condition is becoming most specific with psoriatic and rheumatoid arthritis being ideal paradigms with treatment options diverging after decades of common therapies, as illustrated by IL17-targeting approaches. The ultimate result of these advances is towards personalized medicine with an ideal approach being tailored on a single patient, based on a finely tuned definition of the immunogenetics, epigenetics, microbiome, and biomarkers. Finally, experimental reports suggest that cancer-associated immune mechanisms or the role of T and B cell subpopulations should be better understood in autoimmune diseases. While we hailed the 2014 literature in the autoimmunity world as part of an annus mirabilis, we should not be mistaken in the strong stimulus of research in autoimmunity represented by the 2015 articles that will be summarized in this article.",
keywords = "Epigenetics, Genetics, Immunogenetics, Microbiome, Multiple sclerosis, Psoriasis, Psoriatic arthritis, Rheumatoid arthritis, Systemic lupus erythematosus, Th17, Tolerance breakdown",
author = "Carlo Selmi",
year = "2016",
month = "8",
day = "1",
doi = "10.1007/s12016-016-8576-1",
language = "English (US)",
volume = "51",
pages = "110--119",
journal = "Clinical Reviews in Allergy and Immunology",
issn = "1080-0549",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Autoimmunity in 2015

AU - Selmi, Carlo

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Compared to the clear trend observed in previous years, the number of peer-reviewed articles published during 2015 and retrieved using the “autoimmunity” key word declined by 4 %, while remaining 5 % of immunology articles. On the other hand, a more detailed analysis of the published articles in leading immunology and autoimmunity journals revealed exciting scenarios, with fascinating lines of evidence being supported by convincing data and likely followed by rapid translational or clinical developments. As examples, the study of the microbiome, the development of new serum or other tissue biomarkers, and a more solid understanding of disease pathogenesis and tolerance breakdown mechanisms have been central issues in the past year. Furthermore and similar to the oncology field, progress in the understanding of single autoimmune condition is becoming most specific with psoriatic and rheumatoid arthritis being ideal paradigms with treatment options diverging after decades of common therapies, as illustrated by IL17-targeting approaches. The ultimate result of these advances is towards personalized medicine with an ideal approach being tailored on a single patient, based on a finely tuned definition of the immunogenetics, epigenetics, microbiome, and biomarkers. Finally, experimental reports suggest that cancer-associated immune mechanisms or the role of T and B cell subpopulations should be better understood in autoimmune diseases. While we hailed the 2014 literature in the autoimmunity world as part of an annus mirabilis, we should not be mistaken in the strong stimulus of research in autoimmunity represented by the 2015 articles that will be summarized in this article.

AB - Compared to the clear trend observed in previous years, the number of peer-reviewed articles published during 2015 and retrieved using the “autoimmunity” key word declined by 4 %, while remaining 5 % of immunology articles. On the other hand, a more detailed analysis of the published articles in leading immunology and autoimmunity journals revealed exciting scenarios, with fascinating lines of evidence being supported by convincing data and likely followed by rapid translational or clinical developments. As examples, the study of the microbiome, the development of new serum or other tissue biomarkers, and a more solid understanding of disease pathogenesis and tolerance breakdown mechanisms have been central issues in the past year. Furthermore and similar to the oncology field, progress in the understanding of single autoimmune condition is becoming most specific with psoriatic and rheumatoid arthritis being ideal paradigms with treatment options diverging after decades of common therapies, as illustrated by IL17-targeting approaches. The ultimate result of these advances is towards personalized medicine with an ideal approach being tailored on a single patient, based on a finely tuned definition of the immunogenetics, epigenetics, microbiome, and biomarkers. Finally, experimental reports suggest that cancer-associated immune mechanisms or the role of T and B cell subpopulations should be better understood in autoimmune diseases. While we hailed the 2014 literature in the autoimmunity world as part of an annus mirabilis, we should not be mistaken in the strong stimulus of research in autoimmunity represented by the 2015 articles that will be summarized in this article.

KW - Epigenetics

KW - Genetics

KW - Immunogenetics

KW - Microbiome

KW - Multiple sclerosis

KW - Psoriasis

KW - Psoriatic arthritis

KW - Rheumatoid arthritis

KW - Systemic lupus erythematosus

KW - Th17

KW - Tolerance breakdown

UR - http://www.scopus.com/inward/record.url?scp=84978880098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978880098&partnerID=8YFLogxK

U2 - 10.1007/s12016-016-8576-1

DO - 10.1007/s12016-016-8576-1

M3 - Review article

AN - SCOPUS:84978880098

VL - 51

SP - 110

EP - 119

JO - Clinical Reviews in Allergy and Immunology

JF - Clinical Reviews in Allergy and Immunology

SN - 1080-0549

IS - 1

ER -